Administrative Core
Administrative Core
批准号:
10747154
负责人:
LONNY R LEVIN
金额:
$25.12万
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-08-10 至 2026-05-31
关键词:
Adenylate CyclaseAdvisory CommitteesAffectAnimal ModelBiochemistryBiological AvailabilityBiotechnologyCharacteristicsChemicalsCommunicationComputer ModelsContraceptive AgentsContraceptive methodsCrystallographyDataDrug KineticsElementsEnsureEnzymatic BiochemistryEvaluationFertilizationFosteringFundingGoalsHumanHuman ResourcesInfertilityInstitutionInstitutional Review BoardsInvestigational New Drug ApplicationLeadLinkMaintenanceMale Contraceptive AgentsMarketingMedicineMusNational Institute of Child Health and Human DevelopmentOralOral ContraceptivesPartner in relationshipPharmaceutical ChemistryPharmaceutical PreparationsPharmacologic SubstancePharmacologyPhysiologyPositioning AttributePrincipal InvestigatorPropertyQuality ControlReproductive BiologyResearchResearch ActivityResearch PersonnelResourcesSeriesSperm MotilityStructureTherapeuticTimeWorkcontraceptive efficacydesigndrug developmentdrug discoverydrug qualityearly phase clinical trialimprovedin vivoinhibitormalemating behaviormembermenoutreachpharmacodynamic biomarkerpharmacologicpillpreclinical developmentpreferencepreventprogramsrecruitscaffoldsperm cellstructural biologytool
中文摘要
管理的核心
英文摘要
Administrative Core
The objective of the Administrative Core is to link together the various elements of the Weill Cornell
Medicine Contraception Research Center (WCM-CRC). This center, titled “On-demand nonhormonal male
contraception via ADCY10 inhibition,” has a singular scientific theme; to identify the safest and most
efficacious means for blocking soluble adenylyl cyclase (sAC; ADCY10) in vivo to achieve an on-demand
contraceptive pill for men. To achieve this goal, the WCM-CRC leverages the established inter-disciplinary
team comprised of expertise in sAC physiology, pharmacology, biochemistry, reproductive biology,
structural biology, enzymology, computational modeling, medicinal chemistry, and drug development. This
team, which has been effectively and efficiently working together for the past 4 years, successfully
advanced sAC inhibitors into potent, specific, drug-like leads that demonstrated proof-of-concept for on-
demand male contraception in vivo in mice. This administrative core mirrors the successful administrative
core from the previously funded WCM-CRC; all personnel and operational resources are maintained. Due
to the advancements made over the past four years, the WCM-CRC investigative team joined forces with
an expert in reproductive biology and an expert in contraceptive marketing and end-user preferences to
form Sacyl Pharmaceuticals, Inc. (SACYL), a biotech company established to further develop and market
sAC inhibitors as nonhormonal, on-demand birth control pills for men. SACYL will provide `Pharma-quality'
drug development expertise to augment the work proposed in this application. In addition to ensuring that
the established group of collaborators comprising the WCM-CRC functions as a single entity, the WCM-
CRC Administrative Core will be responsible for maintaining complementarity between the WCM-CRC and
SACYL as well as fostering interactions between the WCM-CRC and NICHD program personnel,
investigators in other CRCs, and regulatory agencies. The Core's administrative responsibilities include
planning, flow of information, developing resources, outreach, and overall administration for the WCM-
CRC. In practice, the WCM-CRC Administrative Core will provide structure and oversight for the already
existing relationships between the two co-Principal Investigators, the other project leaders, SACYL, and
the Center's advisory committees.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Optimization of in vivo validated ADCY10 inhibitors
-
批准号:10747156
-
项目类别:
-
资助金额:$39.56万
-
财政年份:2023
-
负责人:LONNY R LEVIN
-
依托单位:
Target Engagement
-
批准号:10747155
-
项目类别:
-
资助金额:$25.46万
-
财政年份:2023
-
负责人:LONNY R LEVIN
-
依托单位:
Neuronal growth factor signaling via cAMP
-
批准号:7342124
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2007
-
负责人:LONNY R LEVIN
-
依托单位:
Neuronal growth factor signaling via cAMP
-
批准号:7194673
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2007
-
负责人:LONNY R LEVIN
-
依托单位:
Neuronal growth factor signaling via cAMP
-
批准号:7738937
-
项目类别:
-
资助金额:$36.38万
-
财政年份:2007
-
负责人:LONNY R LEVIN
-
依托单位:
Neuronal growth factor signaling via cAMP
-
批准号:7535181
-
项目类别:
-
资助金额:$36.75万
-
财政年份:2007
-
负责人:LONNY R LEVIN
-
依托单位:
Neuronal growth factor signaling via cAMP
-
批准号:7935631
-
项目类别:
-
资助金额:$1.01万
-
财政年份:2007
-
负责人:LONNY R LEVIN
-
依托单位:
A new target for malaria drug development
-
批准号:7174209
-
项目类别:
-
资助金额:$36.81万
-
财政年份:2005
-
负责人:LONNY R LEVIN
-
依托单位:
A new target for malaria drug development
-
批准号:7327787
-
项目类别:
-
资助金额:$31.25万
-
财政年份:2005
-
负责人:LONNY R LEVIN
-
依托单位:
A new target for malaria drug development
-
批准号:7012262
-
项目类别:
-
资助金额:$41.01万
-
财政年份:2005
-
负责人:LONNY R LEVIN
-
依托单位:
New target for malaria drug development
-
批准号:6911385
-
项目类别:
-
资助金额:$33.6万
-
财政年份:2005
-
负责人:LONNY R LEVIN
-
依托单位:
SOLUBLE ADENYLYL CYCLASE ACTIVITY IN MALE GERM CELLS
-
批准号:6261314
-
项目类别:
-
资助金额:$30.51万
-
财政年份:2001
-
负责人:LONNY R LEVIN
-
依托单位:
SOLUBLE ADENYLYL CYCLASE ACTIVITY IN MALE GERM CELLS
-
批准号:6499147
-
项目类别:
-
资助金额:$30.51万
-
财政年份:2001
-
负责人:LONNY R LEVIN
-
依托单位:
SOLUBLE ADENYLYL CYCLASE ACTIVITY IN MALE GERM CELLS
-
批准号:6705013
-
项目类别:
-
资助金额:$30.51万
-
财政年份:2001
-
负责人:LONNY R LEVIN
-
依托单位:
SOLUBLE ADENYLYL CYCLASE ACTIVITY IN MALE GERM CELLS
-
批准号:6629134
-
项目类别:
-
资助金额:$30.51万
-
财政年份:2001
-
负责人:LONNY R LEVIN
-
依托单位:
BIOLOGICAL ROLES OF ADENYLYL CYCLASE MODULATION
-
批准号:2459631
-
项目类别:
-
资助金额:$23.94万
-
财政年份:1995
-
负责人:LONNY R LEVIN
-
依托单位:
BIOLOGICAL ROLES OF ADENYLYL CYCLASE MODULATION
-
批准号:2192087
-
项目类别:
-
资助金额:$25.34万
-
财政年份:1995
-
负责人:LONNY R LEVIN
-
依托单位:
BIOLOGICAL ROLES OF ADENYLYL CYCLASE MODULATION
-
批准号:2750026
-
项目类别:
-
资助金额:$24.9万
-
财政年份:1995
-
负责人:LONNY R LEVIN
-
依托单位:
BIOLOGICAL ROLES OF ADENYLYL CYCLASE MODULATION
-
批准号:2192088
-
项目类别:
-
资助金额:$23.02万
-
财政年份:1995
-
负责人:LONNY R LEVIN
-
依托单位:
Administrative Core
-
批准号:10017314
-
项目类别:
-
资助金额:$23.92万
-
财政年份:--
-
负责人:LONNY R LEVIN
-
依托单位:
海外基金